Safety assessment of terazosin in thetreatment of patients with symptomatic benign prostatic hyperplasia: A combined analysis
- 31 July 1994
- Vol. 44 (1), 46-51
- https://doi.org/10.1016/s0090-4295(94)80008-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study GroupArchives of Family Medicine, 1993
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992
- The Safety, Efficacy and Compliance of Terazosin Therapy for Benign Prostatic HyperplasiaJournal of Urology, 1992
- Nonoperative Management of Benign Prostatic HyperplasiaJournal of Urology, 1989
- Contractile properties of human prostate adenomas and the development of infravesical obstructionThe Prostate, 1989
- The Alpha Adrenergic Binding Properties of Terazosin in the Human Prostate Adenoma and Canine BrainJournal of Urology, 1988
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- Effects of Prazosin in Patients with Benign Prostatic ObstructionJournal of Urology, 1983
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- Alpha-adrenergic blockers in prostatismBritish Journal of Surgery, 1977